StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson specialty Surgery [reported separately through FY2019Q4] — U.S. operational growth YoY (%) (%)

Form 8-K EX-99.2 Segment Sales Schedule

Latest, Q4 2019
-55.3%
Period ended Dec 29, 2019
Change on a year earlier
-50.1 pts
-5.2% in Q4 2018
History
9 quarters
Since Q4 2017
Sources
9
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecialty Surgery [reported separately through FY2019Q4] — U.S. operational growth YoY (%) (%)Year on yearSource
Q4 2019Dec 29, 2019-55.3%-50.1 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
Q3 2019Sep 29, 2019-48.0%-46.9 ptsForm 8-K (a2019q3exhibit991.htm, filed 2019-10-15) ↗
Q2 2019Jun 30, 2019-53.1%-50.5 ptsForm 8-K (a2019q2exhibit9915.htm, filed 2019-07-16) ↗
Q1 2019Mar 31, 2019-2.5%-0.8 ptsForm 8-K (a2019q1exhibit9915.htm, filed 2019-04-16) ↗
Q4 2018Dec 30, 2018-5.2%+4.6 ptsForm 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
Q3 2018Sep 30, 2018-1.1%–Form 8-K (a8k2018q3exhibit9915.htm, filed 2018-10-16) ↗
Q2 2018Jul 1, 2018-2.6%–Form 8-K (a8k2018q2exhibit9915.htm, filed 2018-07-17) ↗
Q1 2018Apr 1, 2018-1.7%–Form 8-K (a8k2018q1exhibit9915.htm, filed 2018-04-17) ↗
Q4 2017Dec 31, 2017-9.8%–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4] — U.S. operational growth YoY (%) (%), quarterly Q4 2017–Q4 2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt_surg_specialty_us_ops_yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.